MANGALAM DRUGS Share price, NSE/BSE Forecast News and Quotes| Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS Share Price   (MANGD)

Here is the latest stock price and chart of MANGALAM DRUGS. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jul 19, 2018 (Close)
Price (Rs)79.15 Open (Rs) 83.45 High (Rs) 83.45 Low (Rs) 79.15
% Change-4.98 Volume 13,227 Value (Rs) 1,059,114 52-Week H/L 225.90 / 79.15
Live NSE Quotes Jul 19, 2018 (Close)
Price (Rs)79.25 Open (Rs) 83.30 High (Rs) 84.60 Low (Rs) 79.25
% Change-4.98 Volume 19,501 Value (Rs) 1,557,638 52-Week H/L 225.70 / 79.25
  BSE Sensex | CNX Nifty


MANGALAM DRUGS Share Price Today:

MANGALAM DRUGS last traded price was down 5.0% to Rs 79.2 on the BSE. On the NSE, MANGALAM DRUGS last traded price was down 5.0% to Rs 79.3. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.3%. And the benchmark S&P BSE SENSEX was at 36,351.2 (down 0.1%).

Over the last 30 days, the MANGALAM DRUGS share price is down 23.5%. And over the last one year, MANGALAM DRUGS share price is down 52.8%.





Today's Market

Sensex Ends Volatile Day Flat; Pharma Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day flat.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MANGALAM DRUGS

  • Track your investment in MANGALAM DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS